Functions of the MDM2 oncoprotein
D A Freedman1, L Wu, A J Levine
1Princeton University, Department of Molecular Biology, Lewis Thomas Laboratory, New Jersey 08544, USA.
Cellular and Molecular Life Sciences : CMLS
|March 5, 1999
Summary
The p53 protein, a tumor suppressor, is regulated by MDM2. MDM2 targets p53 for degradation, but UV radiation initially decreases MDM2, activating p53. This interaction offers cancer therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The p53 protein is a crucial tumor suppressor activated by cellular stress.
- MDM2 oncoprotein is a key regulator of p53 stability and activity.
- A feedback loop exists where p53 induces MDM2, which then inhibits p53.
Purpose of the Study:
- To elucidate the regulatory relationship between p53 and MDM2.
- To identify potential therapeutic targets in cancer treatment.
- To understand the role of MDM2 in p53 nuclear-cytoplasmic transport and degradation.
Main Methods:
- The study describes the molecular interactions and regulatory mechanisms between p53 and MDM2.
- It details the impact of UV irradiation on MDM2 and p53 levels.
- The research outlines the process of p53 degradation mediated by MDM2.
Main Results:
- UV irradiation initially reduces MDM2, leading to p53 activation and cell cycle arrest or apoptosis.
- Post-DNA repair, p53-dependent MDM2 induction inhibits p53 activity and promotes its degradation.
- MDM2 functions as a nuclear-cytoplasmic shuttle for p53 degradation in the proteasome.
Conclusions:
- The p53-MDM2 autoregulatory loop is critical for cellular response to DNA damage.
- MDM2's role in p53 regulation presents multiple opportunities for cancer therapeutic intervention.
- MDM2 itself may possess oncogenic functions independent of p53 inhibition, making it a potential therapeutic target.
Related Concept Videos
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...